Annual report pursuant to Section 13 and 15(d)

Convertible Notes Payable (Details Narrative)

v3.19.1
Convertible Notes Payable (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jan. 31, 2018
Nov. 24, 2017
May 31, 2018
Dec. 31, 2018
Dec. 31, 2017
Debt conversion price per share     $ 1.90    
Gross proceeds from convertible debt       $ 7,684 $ 3,000
Number of common stock issued       $ 7,684 $ 3,000
Shares issued price per share       $ 3.60  
Board of Directors [Member]          
Convertible note interest rate, percentage     8.00%    
Debt conversion price per share     $ 1.90    
Accrued interest     $ 2,062    
Debt conversion converted instrument, shares issued     1,085,105    
Securities Purchase Agreement [Member]          
Gross proceeds from convertible debt     $ 8,428    
Number of common stock issued     $ 4,435,527    
Shares issued price per share     $ 1.90    
Proceeds from issuance of public offering     $ 7,680    
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member] | OPKO Health, Inc. [Member]          
Debt instrument, principal amount $ 1,000        
Convertible note interest rate, percentage 8.00%        
Debt maturity date Jan. 31, 2020        
Debt conversion price per share $ 8.10        
Gross proceeds from convertible debt $ 10,000        
Securities Purchase Agreement [Member] | Two Accredited Investors [Member] | Convertible Notes [Member]          
Debt instrument, principal amount   $ 1,000      
Convertible note interest rate, percentage   8.00%      
Debt maturity date   Nov. 24, 2019      
Debt conversion price per share   $ 8.10      
Gross proceeds from convertible debt   $ 10,000